Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen Research & Development, LLC
With
Hoffmann-La Roche
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Major Depressive Disorder
Current episode of major depression that has not benefited from at least 1 but no more than 3 adequate treatment regimens
Has as score of \>/= 18 on the Ham-D-17
You may not be if
Pregnant or breast-feeding women
Evidence of age-related cognitive decline or mild dementia
At imminent risk of committing suicide
Has with the exception of major depression, a serious medical or neurological illness, including seizure disorder, stroke, dementia, or Parkinson disease
Has an established diagnosis of bipolar disorder, hypomania, schizoaffective disorder, major depression with psychotic features or schizophrenia
Has had a substance or alcohol abuse or dependence disorder (except nicotine and caffeine) in the 1 year before screening
Clareo Health | Safety and Efficacy of EVT 101 in Treatment-Resistant Depression
